Adjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved invasive disease-free survival compared with ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Ryan Haumschild, PharmD, MS, MBA: With this new agent being FDA-approved and one coming this summer, I think there’s a lot of excitement, at least, amongst us, because I think we recognize the benefit ...

Actionability of Synthetic Data in a Heterogeneous and Rare Health Care Demographic: Adolescents and Young Adults With Cancer Extracting inclusion and exclusion criteria in a structured, automated ...

Please provide your email address to receive an email when new articles are posted on . Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology ...

By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Managed Care is the subject of a report. According to news reporting originating in Aurora, United States, by NewsRx ...

Please provide your email address to receive an email when new articles are posted on . NEWPORT BEACH, Calif. — Patient factors that can impact outcomes after same-day total joint reconstruction ...

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...